Figures & data
Figure 1 (A) Scanning electron microscopic and (B) transmission electron microscopic images of the morphology of mesoporous bioactive glass.
Note: Arrow represents mesoporous channels.
![Figure 1 (A) Scanning electron microscopic and (B) transmission electron microscopic images of the morphology of mesoporous bioactive glass.Note: Arrow represents mesoporous channels.](/cms/asset/9509b6ca-cc2e-4738-9cfd-4b544773c91e/dijn_a_29819_f0001_c.jpg)
Figure 2 (A) Nitrogen gas sorption isotherms and (B) pore size distribution of mesoporous bioactive glass.
![Figure 2 (A) Nitrogen gas sorption isotherms and (B) pore size distribution of mesoporous bioactive glass.](/cms/asset/f4c9dc38-5ce4-4a4a-a623-f86ccc7a8295/dijn_a_29819_f0002_c.jpg)
Figure 4 Scanning electron microscopic photographs of mesoporous bioactive glass and polyamide composite scaffolds at (A) ×50 and (B) ×5000 magnification.
![Figure 4 Scanning electron microscopic photographs of mesoporous bioactive glass and polyamide composite scaffolds at (A) ×50 and (B) ×5000 magnification.](/cms/asset/20105c45-51b7-4c2b-a782-4aa334725487/dijn_a_29819_f0004_c.jpg)
Figure 5 Attachment of MG-63 cells on mesoporous bioactive glass and polyamide composite scaffolds. Polyamide scaffolds and tissue culture plate were used as controls. Cell attachment is compared to the tissue culture plate control (100%).
Notes: *Statistical analysis: cell attachment ratio for m-BPC were significantly higher than PA and the control (P < 0.05)
Abbreviations: m-BPC, mesoporous bioactive glass and polyamide composite; PA6, polyamide 6; TCP, tissue culture plate.
![Figure 5 Attachment of MG-63 cells on mesoporous bioactive glass and polyamide composite scaffolds. Polyamide scaffolds and tissue culture plate were used as controls. Cell attachment is compared to the tissue culture plate control (100%).Notes: *Statistical analysis: cell attachment ratio for m-BPC were significantly higher than PA and the control (P < 0.05)Abbreviations: m-BPC, mesoporous bioactive glass and polyamide composite; PA6, polyamide 6; TCP, tissue culture plate.](/cms/asset/04b90b60-fa89-4672-9a59-a56c54c80702/dijn_a_29819_f0005_c.jpg)
Figure 6 Phase contrast microscopic photographs of MG-63 cells cultured with (A) mesoporous bioactive glass and polyamide composite scaffolds and (B) and polyamide scaffolds for 4 hours.
![Figure 6 Phase contrast microscopic photographs of MG-63 cells cultured with (A) mesoporous bioactive glass and polyamide composite scaffolds and (B) and polyamide scaffolds for 4 hours.](/cms/asset/0ff46f70-d342-41b0-87c5-8381d8b75e43/dijn_a_29819_f0006_c.jpg)
Figure 7 Macroscopic evaluation of mesoporous bioactive glass and polyamide composite scaffolds implanted into bone defects of rabbit femora for (A) 4 weeks and (B) 12 weeks.
Note: Circle and arrow show the bone defect area site.
![Figure 7 Macroscopic evaluation of mesoporous bioactive glass and polyamide composite scaffolds implanted into bone defects of rabbit femora for (A) 4 weeks and (B) 12 weeks.Note: Circle and arrow show the bone defect area site.](/cms/asset/d0667b91-6cbc-4ce4-b7cf-458ad72fe74d/dijn_a_29819_f0007_c.jpg)
Figure 8 Synchrotron radiation-based microcomputed tomography of a three-dimensional reconstruction of cross-section images of mesoporous bioactive glass and polyamide composite scaffolds implanted into bone defects of rabbit femora for (A) 4 weeks and (B) 12 weeks.
Note: Circle and arrow show the bone defect area site.
![Figure 8 Synchrotron radiation-based microcomputed tomography of a three-dimensional reconstruction of cross-section images of mesoporous bioactive glass and polyamide composite scaffolds implanted into bone defects of rabbit femora for (A) 4 weeks and (B) 12 weeks.Note: Circle and arrow show the bone defect area site.](/cms/asset/c7068331-2d5f-43ed-ae39-2d9df3cd75b5/dijn_a_29819_f0008_c.jpg)
Figure 9 Hematoxylin and eosin stained section of mesoporous bioactive glass and polyamide composite scaffolds implanted into bone defects of rabbit femora for (A and B) 4 weeks (×5 and ×20, respectively) and (C and D) 12 weeks (×5 and ×20, respectively).
Notes: B represents the new bone tissue, M represents the biomaterials.
![Figure 9 Hematoxylin and eosin stained section of mesoporous bioactive glass and polyamide composite scaffolds implanted into bone defects of rabbit femora for (A and B) 4 weeks (×5 and ×20, respectively) and (C and D) 12 weeks (×5 and ×20, respectively).Notes: B represents the new bone tissue, M represents the biomaterials.](/cms/asset/0b68acb7-ba7a-4b26-98a7-d16dd35b5c41/dijn_a_29819_f0009_c.jpg)
Figure 10 Quantitative analysis of the bone defect area replaced by new bone tissue after mesoporous bioactive glass and polyamide composite scaffolds, and polyamide scaffolds were implanted in vivo for 4 weeks and 12 weeks.
Notes: *Statistical analysis: new bone area ratio for m-BPC were significantly higher than PA6 (P < 0.05).
Abbreviations: m-BPC, mesoporous bioactive glass and polyamide composite; PA6, polyamide 6.
![Figure 10 Quantitative analysis of the bone defect area replaced by new bone tissue after mesoporous bioactive glass and polyamide composite scaffolds, and polyamide scaffolds were implanted in vivo for 4 weeks and 12 weeks.Notes: *Statistical analysis: new bone area ratio for m-BPC were significantly higher than PA6 (P < 0.05).Abbreviations: m-BPC, mesoporous bioactive glass and polyamide composite; PA6, polyamide 6.](/cms/asset/c425d478-e55d-45bd-89b9-575ba3e7a056/dijn_a_29819_f0010_c.jpg)